👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Daniel Masud
Psychiatry
English
11,218+
Patients seen
2
Years in practice
5
Publications
1
Languages spoken
About
Dr. Daniel Masud is an experienced Consultant Psychiatrist specialising in General Adult Psychiatry, Addictions, and Adult ADHD, providing expert care for adults with complex mental health presentations. He currently serves as Deputy Lead for Addictions and Extended Services at Nightingale Hospital, where he oversees specialist programs and maintains private practice privileges with exclusive admissions rights.
In addition to his work at Nightingale, Dr. Masud practices at Central Health, one of the UK’s foremost private mental health facilities, and Harbor London, offering discreet, high-acuity care for families and individuals, including international clients. He also holds practicing privileges at NAYA Health, a pioneering centre for Precision Neuromodulation, combining evidence-based rTMS, trauma-informed therapy, and holistic pathways to target the neural root causes of chronic pain, depression, anxiety, trauma, and fatigue.
Dr. Masud co-founded Miracourt to extend the reach of clinically rigorous, person-centred mental healthcare. Across all his work, he is guided by the principle that effective treatment begins with genuine understanding, of the individual, their story, and the context in which their difficulties arise. Central to his approach is the therapeutic relationship, grounded in trust, empathy, and respect for the lived experience of each client. Whether addressing complex diagnostic questions, facilitating recovery from long-standing emotional and behavioural difficulties, or supporting families through care pathways, he remains attuned to the whole person, not just the condition.
He has particular expertise in treatment-resistant depression, addictions, and adult ADHD, and holds an endorsement in Addiction Psychiatry. Dr. Masud is an Approved Clinician under Section 12(2) of the Mental Health Act 1983 (as amended 2007), listed on the Specialist Register, and a licensed practitioner with the General Medical Council (GMC no. 7454427). He supports self-funding clients and is recognised by major private medical insurers, including BUPA, AXA, Aviva, Vitality, WPA, Healix, Allianz, and Cigna.
Throughout his career, Dr. Masud has combined scientific rigour with humane insight, designing personalised treatment plans in high-acuity and specialist services. His practice reflects a balance of expertise, compassion, and collaboration, helping clients move toward recovery with clarity, hope, and lasting change.
In addition to his work at Nightingale, Dr. Masud practices at Central Health, one of the UK’s foremost private mental health facilities, and Harbor London, offering discreet, high-acuity care for families and individuals, including international clients. He also holds practicing privileges at NAYA Health, a pioneering centre for Precision Neuromodulation, combining evidence-based rTMS, trauma-informed therapy, and holistic pathways to target the neural root causes of chronic pain, depression, anxiety, trauma, and fatigue.
Dr. Masud co-founded Miracourt to extend the reach of clinically rigorous, person-centred mental healthcare. Across all his work, he is guided by the principle that effective treatment begins with genuine understanding, of the individual, their story, and the context in which their difficulties arise. Central to his approach is the therapeutic relationship, grounded in trust, empathy, and respect for the lived experience of each client. Whether addressing complex diagnostic questions, facilitating recovery from long-standing emotional and behavioural difficulties, or supporting families through care pathways, he remains attuned to the whole person, not just the condition.
He has particular expertise in treatment-resistant depression, addictions, and adult ADHD, and holds an endorsement in Addiction Psychiatry. Dr. Masud is an Approved Clinician under Section 12(2) of the Mental Health Act 1983 (as amended 2007), listed on the Specialist Register, and a licensed practitioner with the General Medical Council (GMC no. 7454427). He supports self-funding clients and is recognised by major private medical insurers, including BUPA, AXA, Aviva, Vitality, WPA, Healix, Allianz, and Cigna.
Throughout his career, Dr. Masud has combined scientific rigour with humane insight, designing personalised treatment plans in high-acuity and specialist services. His practice reflects a balance of expertise, compassion, and collaboration, helping clients move toward recovery with clarity, hope, and lasting change.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Daniel Masud
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Psychiatry
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Psychiatry
Malpractice insurance:
HDI Global · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| Psychiatric evaluation | 90791 | 540 |
| Medication management | 90833 | 1,699 |
| CBT session (45m) | 90834 | 1,476 |
| Family therapy | 90847 | 2,825 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 360.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 180.00 EUR |
| CBT session (45m) | 30 min | in_clinic | 1,620.00 EUR |
| Family therapy | 60 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 20 · i10: 4
-
European registry analysis of Psychiatry outcomes
DOI: 10.6500/euroclin.2025.0 · PMID: 34529812 · cited by 153
-
Outcomes of Psychiatry in adults — a multi-centre cohort
DOI: 10.8464/euroclin.2024.1 · PMID: 36110708 · cited by 59
-
European registry analysis of Psychiatry outcomes
DOI: 10.4934/euroclin.2023.2 · PMID: 33586759 · cited by 197
Invited talks
- Practical updates in Psychiatry European Annual Congress (Psychiatry) · Vienna · 2024 · invited
- Single-centre experience in Psychiatry National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Psychiatry — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- European Psychiatric Association — Member · since 2028
- World Psychiatric Association — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.73
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.88
- Value For Money
- 4.90
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Psychiatry
- Awareness When should you see a psychiatry?
For international patients
- Coordinator
- Patient liaison · daniel.masud@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
